128 related articles for article (PubMed ID: 31255484)
1. Discovery of 1,2,3-triazole-based fibroblast growth factor receptor modulators.
Sakai H; Inoue H; Toba T; Murata K; Narii N; Shimmyo Y; Igawa Y; Matsumoto T; Takemoto N
Bioorg Med Chem Lett; 2019 Aug; 29(16):2332-2337. PubMed ID: 31255484
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor receptor modulators employing diamines with reduced phospholipidosis-inducing potential.
Sakai H; Inoue H; Murata K; Toba T; Shimmyo Y; Narii N; Ueno SY; Igawa Y; Takemoto N
Bioorg Med Chem; 2020 Jul; 28(14):115562. PubMed ID: 32616184
[TBL] [Abstract][Full Text] [Related]
3. Multi-target-directed triazole derivatives as promising agents for the treatment of Alzheimer's disease.
Kaur A; Mann S; Kaur A; Priyadarshi N; Goyal B; Singhal NK; Goyal D
Bioorg Chem; 2019 Jun; 87():572-584. PubMed ID: 30928879
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating properties targeting Alzheimer's disease.
Iraji A; Firuzi O; Khoshneviszadeh M; Tavakkoli M; Mahdavi M; Nadri H; Edraki N; Miri R
Eur J Med Chem; 2017 Dec; 141():690-702. PubMed ID: 29107423
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel diosgenin-triazole hybrids targeting inflammation as potential neuroprotective agents.
Huang Y; Huang W; Yang G; Wang R; Ma L
Bioorg Med Chem Lett; 2021 Jul; 43():128092. PubMed ID: 33964436
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and neuroprotective effects of novel chalcone-triazole hybrids.
Sooknual P; Pingaew R; Phopin K; Ruankham W; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Bioorg Chem; 2020 Dec; 105():104384. PubMed ID: 33130346
[TBL] [Abstract][Full Text] [Related]
7. Triazolbenzo[d]thiazoles: efficient synthesis and biological evaluation as neuroprotective agents.
Avila B; Roth A; Streets H; Dwyer DS; Kurth MJ
Bioorg Med Chem Lett; 2012 Sep; 22(18):5976-8. PubMed ID: 22892117
[TBL] [Abstract][Full Text] [Related]
8. Triazole derivatives as inhibitors of Alzheimer's disease: Current developments and structure-activity relationships.
Xu M; Peng Y; Zhu L; Wang S; Ji J; Rakesh KP
Eur J Med Chem; 2019 Oct; 180():656-672. PubMed ID: 31352246
[TBL] [Abstract][Full Text] [Related]
9. Neuritogenic activity of bi-functional bis-tryptoline triazole.
Jiaranaikulwanitch J; Tadtong S; Govitrapong P; Fokin VV; Vajragupta O
Bioorg Med Chem; 2017 Feb; 25(3):1195-1201. PubMed ID: 28043778
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Chemistry and Therapeutic Potential of Triazoles: A Comprehensive Literature Review.
Jain A; Piplani P
Mini Rev Med Chem; 2019; 19(16):1298-1368. PubMed ID: 30864516
[TBL] [Abstract][Full Text] [Related]
11. Substitution of terminal amide with 1H-1,2,3-triazole: Identification of unexpected class of potent antibacterial agents.
Bi F; Ji S; Venter H; Liu J; Semple SJ; Ma S
Bioorg Med Chem Lett; 2018 Mar; 28(5):884-891. PubMed ID: 29433923
[TBL] [Abstract][Full Text] [Related]
12. Novel 4-triazole phenyl amide (4-TPA) molecules: Potent promoters of α-synuclein fibril disassembly.
Qiu C; Wei R; Bian J; Lin X; Bai T; He J; Guo X; Chu Y
Eur J Med Chem; 2024 Jul; 273():116490. PubMed ID: 38772136
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and anti-Alzheimer's activity of novel 1,2,3-triazole-chromenone carboxamide derivatives.
Rastegari A; Nadri H; Mahdavi M; Moradi A; Mirfazli SS; Edraki N; Moghadam FH; Larijani B; Akbarzadeh T; Saeedi M
Bioorg Chem; 2019 Mar; 83():391-401. PubMed ID: 30412794
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of novel 1,2,3-triazole-based acetylcholinesterase inhibitors with neuroprotective activity.
Li JC; Zhang J; Rodrigues MC; Ding DJ; Longo JP; Azevedo RB; Muehlmann LA; Jiang CS
Bioorg Med Chem Lett; 2016 Aug; 26(16):3881-5. PubMed ID: 27426301
[TBL] [Abstract][Full Text] [Related]
15. Discovery of highly potent triazole antifungal derivatives by heterocycle-benzene bioisosteric replacement.
Jiang Z; Wang Y; Wang W; Wang S; Xu B; Fan G; Dong G; Liu Y; Yao J; Miao Z; Zhang W; Sheng C
Eur J Med Chem; 2013 Jun; 64():16-22. PubMed ID: 23643831
[TBL] [Abstract][Full Text] [Related]
16. Novel pentacyclic triterpenes exhibiting strong neuroprotective activity in SH-SY5Y cells in salsolinol- and glutamate-induced neurodegeneration models.
Gonzalez G; Hodoň J; Kazakova A; D'Acunto CW; Kaňovský P; Urban M; Strnad M
Eur J Med Chem; 2021 Mar; 213():113168. PubMed ID: 33508480
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel diaryl urea derivatives bearing a triazole moiety as potential antitumor agents.
Qin M; Yan S; Wang L; Zhang H; Zhao Y; Wu S; Wu D; Gong P
Eur J Med Chem; 2016 Jun; 115():1-13. PubMed ID: 26991938
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and CYP26A1 inhibitory activity of 1-[benzofuran-2-yl-(4-alkyl/aryl-phenyl)-methyl]-1H-triazoles.
Pautus S; Yee SW; Jayne M; Coogan MP; Simons C
Bioorg Med Chem; 2006 Jun; 14(11):3643-53. PubMed ID: 16458519
[TBL] [Abstract][Full Text] [Related]
19. Novel purine-based fluoroaryl-1,2,3-triazoles as neuroprotecting agents: synthesis, neuronal cell culture investigations, and CDK5 docking studies.
Nair N; Kudo W; Smith MA; Abrol R; Goddard WA; Reddy VP
Bioorg Med Chem Lett; 2011 Jul; 21(13):3957-61. PubMed ID: 21641213
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity study of 1,2,4-triazole derivatives.
Gao F; Wang T; Xiao J; Huang G
Eur J Med Chem; 2019 Jul; 173():274-281. PubMed ID: 31009913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
